CTD Phosphorylation
Main Page:CTD Phosphorylation
Introduction
The C-terminal domain (CTD) of RNA polymerase II's largest subunit undergoes dynamic phosphorylation during transcription, and the different phosphorylation patterns that predominate at each stage of transcription recruit the appropriate set of mRNA-processing and histone-modifying factors. The CTD has multiple phosphorylation sites, with up to five potential phosphorylation sites in a consensus heptapeptide repeat (Y1, S2, T4, S5, S7). In vivo phosphorylation occurs mainly on serine residues. The hyperphosphorylated form of the mammalian CTD has on average 1 phosphate/repeat, although the number of phosphates on the CTD at any point of the transcription cycle has not yet been determined. This complex phosphorylation patterns are regulated by quite a few phosphatases and kinases. Below is the list of known phosphatases and kinases involved in CTD phosphorylation [1].
Phosphatases
Mammals | Yeast | Group | Family | Substrate | Stage | Evolution (from yeast to human) | Note |
---|---|---|---|---|---|---|---|
FCP1 | FCP1 | HAD | FCP | pSer2, pThr4 [2] | To Recycling | From yeast to human | |
SCP | SCP | HAD | FCP | pSer5 | To cleavage, polyA and termination | From yeast to human | The function toward pSer5 of one of its member, SCP1, has been verified in mammals, but not in yeast, yet. |
SSU72 | SSU72 | CC2 | SSU72 | pSer5 | To cleavage, polyA and termination | From yeast to human | 1) Its function toward pSer5 has been verified in yeast, but not mammals. 2) Unlike other phosphatases, it has a fold similar to LMWPTP rather than HAD. |
HSPC129 | N/A | HAD | FCP | ? | ? | From Monosiga to human but lost in fly | 1) In vitro activity toward CTD. 2) HSPC129 was divergent from SCP family. |
UBLCP1 | N/A | HAD | SCP | ? | ? | From anemone to human but lost in nematode | 1) In vitro activity toward CTD. |
? | N/A | ? | ? | pSer7 | ? | ? | Observed phosphorylated pSer7, but the phosphatase and kinase are unknown. |
Kinases
Mammals | Yeast | Group | Family | Subfamily | Substrate | Stage | Evolution | Note |
---|---|---|---|---|---|---|---|---|
CDK7 | KIN28 | CMGC | CDK | CDK7 | Ser5 | To initiation | From yeast to human but lost in Monosiga? | 1) CDK7 is a component of transcription factor TFIIH. 2) KinBase shows it is absent from Monosiga. |
CDK9 | Bur1 | CMGC | CDK | CDK9 | Ser2 | To elongation | From yeast to human but lost in Monosiga? | 1) CDK9 is the catalytic subunit of the positive transcription elongation factor (P-TEF)b complex. 2) KinBase shows it is absent from Monosiga. |
CRK7 | CTK1 | CMGC | CDK | CRK7 | Ser2 | To elongation | From Giardia to human but lost in Tetrahymena | It has been verified in yeast, but not in mammals. |
CDK8 | CDK8 | CMGC | CDK | CDK8 | Ser2 and Ser5 | In the pool of pol II? | From yeast to human | |
CDC2 | CDK1 | CMGC | CDK | CDC2 | Ser2 and Ser5 | In the pool of pol II? | From Giardia to human | In KInbase, conserved in yeast in the tree, but absent in the hits. |
ERK1/2 | FUS3, KSS1, SLT2, SMK1, YKL161C | CMGC | MAPK | ERK1 | Ser5 | In the pool of pol II? | From Monosiga to human | Many yeast proteins in this subfamily of extracellular signal-related kinase 1/2 (ERK1 in KinBase). |
? | ? | ? | ? | ? | Ser7 | ? | ? | ? |
References
- Buratowski S. Progression through the RNA polymerase II CTD cycle. Mol Cell. 2009 Nov 25;36(4):541-6. DOI:10.1016/j.molcel.2009.10.019 |
- Hsin JP, Xiang K, and Manley JL. Function and control of RNA polymerase II C-terminal domain phosphorylation in vertebrate transcription and RNA processing. Mol Cell Biol. 2014 Jul;34(13):2488-98. DOI:10.1128/MCB.00181-14 |
- Akhtar MS, Heidemann M, Tietjen JR, Zhang DW, Chapman RD, Eick D, and Ansari AZ. TFIIH kinase places bivalent marks on the carboxy-terminal domain of RNA polymerase II. Mol Cell. 2009 May 15;34(3):387-93. DOI:10.1016/j.molcel.2009.04.016 |
- Tietjen JR, Zhang DW, Rodríguez-Molina JB, White BE, Akhtar MS, Heidemann M, Li X, Chapman RD, Shokat K, Keles S, Eick D, and Ansari AZ. Chemical-genomic dissection of the CTD code. Nat Struct Mol Biol. 2010 Sep;17(9):1154-61. DOI:10.1038/nsmb.1900 |
- Kim H, Erickson B, Luo W, Seward D, Graber JH, Pollock DD, Megee PC, and Bentley DL. Gene-specific RNA polymerase II phosphorylation and the CTD code. Nat Struct Mol Biol. 2010 Oct;17(10):1279-86. DOI:10.1038/nsmb.1913 |
- Yang XJ. Multisite protein modification and intramolecular signaling. Oncogene. 2005 Mar 3;24(10):1653-62. DOI:10.1038/sj.onc.1208173 |
- Chapman RD, Heidemann M, Hintermair C, and Eick D. Molecular evolution of the RNA polymerase II CTD. Trends Genet. 2008 Jun;24(6):289-96. DOI:10.1016/j.tig.2008.03.010 |
- Stiller JW and Hall BD. Evolution of the RNA polymerase II C-terminal domain. Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):6091-6. DOI:10.1073/pnas.082646199 |
- Egloff S and Murphy S. Cracking the RNA polymerase II CTD code. Trends Genet. 2008 Jun;24(6):280-8. DOI:10.1016/j.tig.2008.03.008 |